Narrow search
Showing 1 - 10 of 15,813
Cover Image
Pharmaceutical innovation : revolutionizing human health
Landau, Ralph (ed.); Achilladelis, Basil (contributor);  … - 1999
Persistent link: https://www.econbiz.de/10001423161
Cover Image
TRIPS flexibilities on patent enforcement : lessons from some developed countries relating to pharmaceutical patent protection
Sarnoff, Joshua D. - 2020
Persistent link: https://www.econbiz.de/10012433661
Cover Image
Evidence of abnormal trading on COVID-19 Pfizer vaccine development information
Mason, Andrew N.; Elkassabgi, Ahmed - In: Journal of risk and financial management : JRFM 15 (2022) 7, pp. 1-10
The 2019 COVID-19 pandemic led to an economic slowdown worldwide and shook the investment world. Pharmaceutical investments were influenced by the anticipation of COVID-19 vaccine developments. Our study examines the real-time impact of public announcements concerning COVID-19 vaccine...
Persistent link: https://www.econbiz.de/10013370364
Cover Image
United States Special 301 : a deeply flawed tool for IPR regulation?
Qureshi, Asif H. - In: Journal of world trade : law, economic policy, public policy 55 (2021) 3, pp. 499-520
Persistent link: https://www.econbiz.de/10012609439
Cover Image
Patents for Covid-19 vaccines are based on public research: a case study on the privatization of knowledge
Florio, Massimo - 2021 - This version October 11, 2021
Persistent link: https://www.econbiz.de/10012642904
Cover Image
Prescription for the people : an activist's guide to making medicine affordable for all
Quigley, Fran - 2017
development of new medicines -- Governments, not private corporations, drive medicine innovation -- Taxpayers and patients pay …
Persistent link: https://www.econbiz.de/10011650107
Cover Image
Pharmaceutical Pricing and R&D as a Global Public Good
Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - National Bureau of Economic Research - 2023
In his Labor Day address, President Biden stated that the U.S. "has the highest drug prices in the world, and there is no reason for it." For new branded drugs, the first part of that statement is supported by a recent RAND Report (Mulcahy et. al. 2021) which found U.S. average prices are 2.3...
Persistent link: https://www.econbiz.de/10014287373
Cover Image
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies
Cohen, I. Glenn (contributor);  … - 2015
responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off …
Persistent link: https://www.econbiz.de/10014481793
Cover Image
How does basic research improve innovation performance in the world's major pharmaceutical firms?
Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424
Persistent link: https://www.econbiz.de/10013170079
Cover Image
The role of cross-national knowledge on organizational ambidexterity : a case of the global pharmaceutical industry
Dunlap, Denise; Marion, Tucker; Friar, John - In: Management learning : the journal for managerial and … 45 (2014) 4, pp. 458-476
Persistent link: https://www.econbiz.de/10010415282